Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease
Anu A Mathew, Nisha Sachdev, Sandra E Staffieri, John D McKenzie, James E Elder
JOURNAL OF AAPOS | MOSBY-ELSEVIER | Published : 2015
We present a case of a child with unilateral group E retinoblastoma (according to the International Classification of Retinoblastoma) who received superselective intra-arterial chemotherapy as primary therapy. Although the tumor showed signs of regression, the patient developed orbital metastases requiring surgical excision and chemotherapy. Eventually the affected eye progressed to total retinal detachment and required enucleation.
Awarded by Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant
Funding support for SES provided by an Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant 1023911 (20122016). The Centre for Eye Research Australia receives operational infrastructure support from the Victorian government.